Lifschitz A, Fiel C, Steffan P, Cantón C, Muchiut S, Dominguez P, Lanusse C, Alvarez L
Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN) (UNCPBA-CICPBA-CONICET), Facultad de Ciencias Veterinarias, UNCPBA, Tandil, Argentina.
Laboratorio de Parasitología y Enfermedades Parasitarias, Centro de Investigación Veterinaria de Tandil (CIVETAN) (UNCPBA-CICPBA-CONICET), Facultad de Ciencias Veterinarias, UNCPBA, Tandil, Argentina.
Vet Parasitol. 2018 Nov 15;263:18-22. doi: 10.1016/j.vetpar.2018.10.006. Epub 2018 Oct 5.
Psoroptic mange is an important parasitic disease that mainly affects beef cattle producing marked economic losses. Ivermectin (IVM) is considered one of the most effective treatments against psoroptic mange and is used worldwide to control both endo and ectoparasites in different species. The current work assessed the relationship between pharmacokinetic behavior of IVM and its efficacy against Psoroptes ovis after the subcutaneous administration of two commercial formulations in a cattle feedlot. Aberdeen Angus and Hereford steers were selected based on the presence of active mite infestations. Animals were allocated into 4 experimental groups and treated with a single (day 0) or repeated subcutaneous injection (days 0 and 7) of one of two commercial formulations of IVM (1%) at 0.2 mg/kg. Blood and skin samples were taken from 8 randomly selected animals of each experimental group to measure IVM concentrations by HPLC. Skin scrapings were also collected from six different sites in each animal, mites were counted and ranked based on a density score. Equivalent plasma concentrations of IVM were measured after the administration of IVM formulations under study. The repeated administration of both IVM formulations at day 0 and 7 accounted for a greater plasma drug availability compared with the single administration (P < 0.05). IVM was well distributed from the plasma to the skin without significant differences between both IVM formulations. There was a positive correlation between IVM concentrations in skin and plasma (r: 0.73 P < 0.0001). The mean ratios between IVM availabililty (measured as AUC) in the skin and in plasma were between 1.2 and 2.1. The repeated administration of IVM increased significantly the IVM concentrations in the skin of areas affected by mange. IVM failed to obtain a parasitological cure in the different groups affected by mange. The failure was observed with both formulations administeredat single or repeated doses. Based on the number of animals cured, the range of efficacy was between 0% on day 7 and 60% on day 28 post-treatment. No significant differences in the P. ovis density scores were observed after the IVM treatment at single or repeated doses. Additional studies are needed to confirm the presence of resistant strains of P.ovis and to establish the appropriate measures to control these parasitic infestations in feedlot cattle.
痒螨病是一种重要的寄生虫病,主要影响肉牛,造成显著的经济损失。伊维菌素(IVM)被认为是治疗痒螨病最有效的药物之一,在全球范围内用于控制不同物种的体内和体外寄生虫。目前的研究评估了在肉牛饲养场皮下注射两种市售制剂后,IVM的药代动力学行为与其对绵羊痒螨的疗效之间的关系。根据是否存在活跃的螨虫感染,选择了阿伯丁安格斯和赫里福德阉牛。将动物分为4个实验组,用两种市售IVM制剂(1%)中的一种以0.2mg/kg的剂量进行单次(第0天)或重复皮下注射(第0天和第7天)。从每个实验组中随机选取8只动物采集血液和皮肤样本,用高效液相色谱法测定IVM浓度。还从每只动物的六个不同部位采集皮肤刮屑,对螨虫进行计数并根据密度评分进行排名。在给予所研究的IVM制剂后,测定其等效血浆浓度。与单次给药相比,在第0天和第7天重复给予两种IVM制剂的血浆药物可用性更高(P<0.05)。IVM从血浆到皮肤分布良好,两种IVM制剂之间无显著差异。皮肤和血浆中的IVM浓度呈正相关(r:0.73,P<0.0001)。皮肤和血浆中IVM可用性(以AUC衡量)的平均比值在1.2至2.1之间。重复给予IVM显著提高了受螨病影响区域皮肤中的IVM浓度。IVM未能使受螨病影响的不同组获得寄生虫学治愈。单次或重复剂量给药的两种制剂均观察到治疗失败。根据治愈动物的数量,疗效范围在治疗后第7天为0%至第28天为60%。单次或重复剂量的IVM治疗后,绵羊痒螨密度评分无显著差异。需要进一步研究以确认绵羊痒螨耐药菌株的存在,并确定控制饲养场牛群中这些寄生虫感染的适当措施。